Q3 2025 Press Conference Call November 13, 2025 4:00 AM ESTCompany ParticipantsPhilipp Schindera - Senior Vice ...
CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit ...
Third quarter 2025 revenue of $9.5 million, up 10% year-over-year Amended credit agreement with Avenue Capital Group which strengthens our balance sheet with ...
To achieve EV potential by squeezing more functionality into a given volume, and delivering value at a compelling price point ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback